Suvretta Capital Management LLC acquired a new position in Agilent Technologies, Inc. (NYSE:A – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,990 shares of the medical research company’s stock, valued at approximately $690,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in A. Delta Asset Management LLC TN acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $26,000. Money Concepts Capital Corp purchased a new stake in Agilent Technologies in the 4th quarter worth $26,000. Ancora Advisors LLC acquired a new position in Agilent Technologies during the fourth quarter worth $34,000. Stone House Investment Management LLC acquired a new position in Agilent Technologies during the first quarter worth $36,000. Finally, Thompson Siegel & Walmsley LLC purchased a new position in Agilent Technologies during the fourth quarter valued at $39,000. Institutional investors and hedge funds own 85.42% of the company’s stock.
Insider Activity at Agilent Technologies
In related news, VP Rodney Gonsalves sold 3,500 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $118.78, for a total value of $415,730.00. Following the sale, the vice president now owns 24,219 shares in the company, valued at approximately $2,876,732.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Agilent Technologies news, CEO Michael R. Mcmullen sold 944 shares of the business’s stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $130.00, for a total value of $122,720.00. Following the completion of the transaction, the chief executive officer now owns 260,869 shares in the company, valued at $33,912,970. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Rodney Gonsalves sold 3,500 shares of the company’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $118.78, for a total value of $415,730.00. Following the sale, the vice president now directly owns 24,219 shares in the company, valued at approximately $2,876,732.82. The disclosure for this sale can be found here. 0.31% of the stock is owned by insiders.
Agilent Technologies Trading Up 0.1 %
Agilent Technologies (NYSE:A – Get Free Report) last announced its earnings results on Tuesday, August 15th. The medical research company reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.07. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.66 billion. Agilent Technologies had a net margin of 16.20% and a return on equity of 29.86%. Agilent Technologies’s revenue was down 2.7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.34 earnings per share. Analysts expect that Agilent Technologies, Inc. will post 5.42 EPS for the current fiscal year.
Analysts Set New Price Targets
A has been the topic of a number of research reports. SVB Securities decreased their price target on shares of Agilent Technologies from $170.00 to $145.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 24th. Barclays lowered their price target on Agilent Technologies from $115.00 to $110.00 and set an “underweight” rating on the stock in a research note on Wednesday, August 16th. JPMorgan Chase & Co. reduced their price objective on Agilent Technologies from $155.00 to $150.00 and set an “overweight” rating for the company in a research note on Wednesday, August 16th. TD Cowen upped their target price on shares of Agilent Technologies from $145.00 to $147.00 and gave the stock an “outperform” rating in a report on Wednesday, August 16th. Finally, Jefferies Financial Group cut their price objective on shares of Agilent Technologies from $150.00 to $146.00 and set a “buy” rating for the company in a report on Wednesday, August 16th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $148.12.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Five stocks we like better than Agilent Technologies
- How to Capture the Benefits of Dividend Increases
- Oil Jumps, 2 Plastic Stocks About To Become Value Plays
- What Does Downgrade Mean in Investing?
- The Top 5 Analysts Calls in September
- Investing in Blue-Chip Stocks
- These are the Top 3 Sectors for 3rd Quarter Profit Growth
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.